Case Report

Thyroidectomy for Painful Thyroiditis Resistant to Steroid Treatment: Three New Cases with Review of the Literature

Table 1

Seventy-three patients with painful thyroiditis observed in the years 1996–2013; clinical and laboratory .

Clinical details Subgroups

Age; years, range, and (median)14.4–75.2 (42.8)

Sex Females 58
Males15

Systemic symptoms and/or fever Yes53
No20

Transient thyrotoxicosisYes44
No29

TPOAb and/or TgAb levels Above reference range19
Absent and/or within reference range43
Unknown11

TRAb in patients with transient thyrotoxicPositive0
Negative35
Unknown9

Thyroid function in 43 cases with absent or normal TPOAb and TgAbTransient thyrotoxicosis28
Euthyroidism during the observation period15

Thyroid function in 19 patients with positive TPOAb and/or TgAbTransient thyrotoxicosis9
Euthyroidism during the observation period6
Already on treatment with thyroxine for hypothyroidism3
euthyroid → Graves’ 1

Thyroid nodules at ultrasonographyYes22
No49

Treatment schedule and Responders to salicylates or NSAIDs11
Responders to 60
Not responders to steroids (this paper, Cases 2 and 3)2

Data are expressed in number of subjects when not otherwise specified in the column “clinical details.”
TPOAb: thyroid peroxidase antibodies; TgAb: thyroglobulin antibodies; TRAb: thyrotropin receptor antibodies.
This patient was euthyroid during the painful phase; about three months after the resolution of painful thyroiditis the patient developed persistent thyrotoxicosis with positive TRAb, necessitating treatment with an antithyroid drug.
Before our observation, 18 patients were unsuccessfully treated with antibiotics; steroids were also sometimes used before our observation, but at doses lower than those subsequently found to be effective.
Patients were treated with prednisone 10–40 mg daily (58 cases) or other steroids in equivalent doses (2 cases). After 7–35 days (median 16) a gradual reduction in dosage could be initiated. Remission occurred in 57 patients. During the period of reduction of dosage or after discontinuation a single relapse was observed in 3 cases, all controlled with restoration of higher steroid dosage.